Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets | npj Genomic Medicine
JCM | Free Full-Text | Is Endothelial Activation a Critical Event in Thrombotic Thrombocytopenic Purpura?
JCM | Free Full-Text | Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise
Neutrophil Extracellular Traps | Arteriosclerosis, Thrombosis, and Vascular Biology
PDF) A Fatal Case of Thrombotic Microangiopathy Without Schistocytosis and Absent Biochemical Markers of Hemolysis
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19 | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Pathophysiological mechanisms of thrombosis in acute and long COVID-19
Diagnosis and treatment of thrombotic microangiopathy - Thompson - 2022 - International Journal of Laboratory Hematology - Wiley Online Library
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium | Nature Reviews Cardiology
Frontiers | Extracellular traps and the role in thrombosis
Occult recurrent breast cancer masquerading as thrombotic thrombocytopenic purpura - Wills‐Sanin - American Journal of Hematology - Wiley Online Library
Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy - ScienceDirect
JCM | Free Full-Text | The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative Review
IJMS | Free Full-Text | PLVAP as an Early Marker of Glomerular Endothelial Damage in Mice with Diabetic Kidney Disease
Thrombotic Microangiopathy Syndromes—Common Ground and Distinct Frontiers - ScienceDirect
Thrombotic thrombocytopenic purpura | Nature Reviews Disease Primers
Diagnostics | Free Full-Text | Pitfalls of Thrombotic Microangiopathies in Children: Two Case Reports and Literature Review
Cell-Free DNA: An Upcoming Biomarker in Transplantation - American Journal of Transplantation
Frontiers | Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?
Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice - ScienceDirect
JCM | Free Full-Text | Immune and Hereditary Thrombotic Thrombocytopenic Purpura: Can ADAMTS13 Deficiency Alone Explain the Different Clinical Phenotypes?
Thrombotic Microangiopathies and Stem Cell Transplant – AJKD Blog
IJMS | Free Full-Text | Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome
IJMS | Free Full-Text | Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms
Frontiers | Extracellular DNA—A Danger Signal Triggering Immunothrombosis
